[Diseases caused by Serratia marcescens (Prodigiosus)].
D001424:Bacterial Infections / Q000188:drug therapy; D002228:Carbenicillin / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy; D004756:Enterobacteriaceae Infections; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D008581:Meningitis / Q000188:drug therapy; D008826:Microbial Sensitivity Tests; D009268:Nalidixic Acid / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy; D012706:Serratia marcescens / Q000472:pathogenicity*
D005839:Gentamicins; D009268:Nalidixic Acid; D007612:Kanamycin; D002701:Chloramphenicol; D002228:Carbenicillin
Durch Serratia marcescens ("Prodigiosus") verursachte Krankheiten.